← Every applicant

Ascent Pharms Inc FDA Approvals

33 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
CLOMIPHENE CITRATENew drugMay 15, 2026TABLET, ORAL
GUANFACINE HYDROCHLORIDENew drugMar 24, 2026TABLET, ORAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDENew drugJan 21, 2026FILM, BUCCAL, SUBLINGUAL
TOPIRAMATENew drugJan 12, 2026CAPSULE, EXTENDED RELEASE, ORAL
BUPRENORPHINE HYDROCHLORIDENew drugDec 18, 2025TABLET, SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDENew drugDec 15, 2025TABLET, SUBLINGUAL
SODIUM OXYBATENew drugNov 5, 2025SOLUTION, ORAL
ESCITALOPRAM OXALATENew drugJul 15, 2025TABLET, ORAL
RIVAROXABANNew drugMay 14, 2025TABLET, ORAL
POTASSIUM CHLORIDENew drugApr 9, 2025SOLUTION, ORAL
CARBIDOPA AND LEVODOPANew drugJan 14, 2025TABLET, ORAL
LUBIPROSTONENew drugJan 2, 2025CAPSULE, ORAL
BEXAROTENENew drugSep 6, 2024CAPSULE, ORAL
ICOSAPENT ETHYLNew drugDec 7, 2023CAPSULE, ORAL
LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023CAPSULE, ORAL
LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023TABLET, CHEWABLE, ORAL
PALIPERIDONENew drugAug 23, 2023TABLET, EXTENDED RELEASE, ORAL
MELOXICAMNew drugJun 7, 2023TABLET, ORAL
IBUPROFEN AND FAMOTIDINENew drugMar 15, 2023TABLET, ORAL
LEVOTHYROXINE SODIUMNew drugJan 18, 2023TABLET, ORAL
TAMSULOSIN HYDROCHLORIDENew drugMay 4, 2022CAPSULE, ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDENew drugDec 8, 2021CAPSULE, EXTENDED RELEASE, ORAL
FAMOTIDINENew drugNov 3, 2021TABLET, ORAL
FAMOTIDINENew drugOct 15, 2021TABLET, ORAL
GABAPENTINNew drugOct 1, 2021TABLET, ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugSep 29, 2021CAPSULE, EXTENDED RELEASE, ORAL
TOPIRAMATENew drugAug 26, 2021TABLET, ORAL
GABAPENTINNew drugMay 10, 2021CAPSULE, ORAL
SERTRALINE HYDROCHLORIDENew drugMay 3, 2021TABLET, ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugApr 22, 2021TABLET, ORAL
POTASSIUM CITRATENew drugFeb 5, 2021TABLET, EXTENDED RELEASE, ORAL
METHYLPHENIDATE HYDROCHLORIDENew drugJan 29, 2021SOLUTION, ORAL
GEMFIBROZILNew drugJan 13, 2021TABLET, ORAL

Related datasets